| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | small GTPase binding | MICAL1 SIKE1 RABGAP1 TRIP11 GGA3 EVI5 AP1G1 ROCK1 EVI5L RAB11FIP3 | 6.29e-05 | 321 | 134 | 10 | GO:0031267 |
| GeneOntologyMolecularFunction | GTPase binding | MICAL1 SIKE1 RABGAP1 TRIP11 GGA3 EVI5 AP1G1 ROCK1 EVI5L RAB11FIP3 | 1.61e-04 | 360 | 134 | 10 | GO:0051020 |
| GeneOntologyMolecularFunction | kinase activity | GAK NEK7 DGKD IP6K1 PFKFB2 PFKFB3 ACVR1B TRRAP MET KSR1 LIMK1 NRK ROCK1 MAP3K13 ATM | 1.92e-04 | 764 | 134 | 15 | GO:0016301 |
| GeneOntologyMolecularFunction | 6-phosphofructo-2-kinase activity | 2.66e-04 | 4 | 134 | 2 | GO:0003873 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | GAK NEK7 DGKD IP6K1 PFKFB2 PFKFB3 ACVR1B MET KSR1 LIMK1 NRK ROCK1 MAP3K13 ATM | 2.99e-04 | 709 | 134 | 14 | GO:0016773 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | VAPA MICAL1 KIF23 PACSIN1 NCKIPSD RABGAP1 RAB3C DST AP1G1 MYH14 FRG1 TLN1 SYNE2 CEP70 ROCK1 TLN2 JAKMIP1 UTRN | 4.02e-04 | 1099 | 134 | 18 | GO:0008092 |
| GeneOntologyMolecularFunction | testosterone 6-beta-hydroxylase activity | 4.41e-04 | 5 | 134 | 2 | GO:0050649 | |
| GeneOntologyMolecularFunction | pheromone binding | 4.41e-04 | 5 | 134 | 2 | GO:0005550 | |
| GeneOntologyMolecularFunction | fructose-2,6-bisphosphate 2-phosphatase activity | 4.41e-04 | 5 | 134 | 2 | GO:0004331 | |
| GeneOntologyMolecularFunction | phosphofructokinase activity | 9.18e-04 | 7 | 134 | 2 | GO:0008443 | |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | GAK LZTS3 PACSIN1 NCKIPSD ATP8B1 RABGAP1 EVI5 MET NLGN3 LIMK1 SYNE2 VPS35 RTCA MAP3K13 RAB21 PLXNB1 EVI5L RAB11FIP3 | 6.13e-06 | 846 | 130 | 18 | GO:0120035 |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | GAK LZTS3 PACSIN1 NCKIPSD ATP8B1 RABGAP1 EVI5 MET NLGN3 LIMK1 SYNE2 VPS35 RTCA MAP3K13 RAB21 PLXNB1 EVI5L RAB11FIP3 | 8.04e-06 | 863 | 130 | 18 | GO:0031344 |
| Domain | DUF1220 | 3.01e-07 | 9 | 133 | 4 | SM01148 | |
| Domain | DUF1220 | 7.80e-07 | 11 | 133 | 4 | PF06758 | |
| Domain | NBPF_dom | 7.80e-07 | 11 | 133 | 4 | IPR010630 | |
| Domain | NBPF | 7.80e-07 | 11 | 133 | 4 | PS51316 | |
| Domain | - | 5.03e-05 | 2 | 133 | 2 | 1.20.1420.10 | |
| Domain | VBS | 5.03e-05 | 2 | 133 | 2 | PF08913 | |
| Domain | Vinculin-bd_dom | 5.03e-05 | 2 | 133 | 2 | IPR015009 | |
| Domain | Talin_cent | 5.03e-05 | 2 | 133 | 2 | IPR015224 | |
| Domain | Talin_middle | 5.03e-05 | 2 | 133 | 2 | PF09141 | |
| Domain | SIKE | 5.03e-05 | 2 | 133 | 2 | IPR008555 | |
| Domain | DUF837 | 5.03e-05 | 2 | 133 | 2 | PF05769 | |
| Domain | Coatomer/clathrin_app_Ig-like | 7.41e-05 | 12 | 133 | 3 | IPR013041 | |
| Domain | CH | 9.96e-05 | 65 | 133 | 5 | SM00033 | |
| Domain | CH | 1.42e-04 | 70 | 133 | 5 | PF00307 | |
| Domain | Talin-1 | 1.50e-04 | 3 | 133 | 2 | IPR015710 | |
| Domain | von_Ebner_gland | 1.50e-04 | 3 | 133 | 2 | IPR002450 | |
| Domain | - | 1.52e-04 | 71 | 133 | 5 | 1.10.418.10 | |
| Domain | CH | 1.73e-04 | 73 | 133 | 5 | PS50021 | |
| Domain | CH-domain | 1.97e-04 | 75 | 133 | 5 | IPR001715 | |
| Domain | ILWEQ_dom | 2.99e-04 | 4 | 133 | 2 | IPR002558 | |
| Domain | ILWEQ | 2.99e-04 | 4 | 133 | 2 | SM00307 | |
| Domain | FERM_f0 | 2.99e-04 | 4 | 133 | 2 | PF16511 | |
| Domain | 6Phosfructo_kin | 2.99e-04 | 4 | 133 | 2 | IPR013079 | |
| Domain | ILWEQ | 2.99e-04 | 4 | 133 | 2 | PD011820 | |
| Domain | - | 2.99e-04 | 4 | 133 | 2 | 1.20.1410.10 | |
| Domain | I_LWEQ | 2.99e-04 | 4 | 133 | 2 | PF01608 | |
| Domain | I_LWEQ | 2.99e-04 | 4 | 133 | 2 | PS50945 | |
| Domain | FERM_f0 | 2.99e-04 | 4 | 133 | 2 | IPR032425 | |
| Domain | 6Pfruct_kin | 2.99e-04 | 4 | 133 | 2 | IPR003094 | |
| Domain | 6PF2K | 2.99e-04 | 4 | 133 | 2 | PF01591 | |
| Domain | GAE | 4.96e-04 | 5 | 133 | 2 | PS50180 | |
| Domain | Cyt_P450_E_grp-II | 4.96e-04 | 5 | 133 | 2 | IPR002402 | |
| Domain | Kinase-like_dom | GAK NEK7 ACVR1B TRRAP MET KSR1 LIMK1 DST NRK ROCK1 MAP3K13 ATM | 5.01e-04 | 542 | 133 | 12 | IPR011009 |
| Domain | Spectrin | 5.63e-04 | 23 | 133 | 3 | PF00435 | |
| Domain | ACTININ_2 | 5.63e-04 | 23 | 133 | 3 | PS00020 | |
| Domain | ACTININ_1 | 5.63e-04 | 23 | 133 | 3 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 5.63e-04 | 23 | 133 | 3 | IPR001589 | |
| Domain | Cyt_P450_E_CYP3A | 7.41e-04 | 6 | 133 | 2 | IPR008072 | |
| Domain | - | 7.41e-04 | 6 | 133 | 2 | 2.60.40.1230 | |
| Domain | Clathrin_g-adaptin_app | 7.41e-04 | 6 | 133 | 2 | IPR008153 | |
| Domain | FAT | 7.41e-04 | 6 | 133 | 2 | PS51189 | |
| Domain | FATC | 7.41e-04 | 6 | 133 | 2 | PS51190 | |
| Domain | FAT | 7.41e-04 | 6 | 133 | 2 | PF02259 | |
| Domain | PIK-rel_kinase_FAT | 7.41e-04 | 6 | 133 | 2 | IPR003151 | |
| Domain | FATC_dom | 7.41e-04 | 6 | 133 | 2 | IPR003152 | |
| Domain | PIK_FAT | 7.41e-04 | 6 | 133 | 2 | IPR014009 | |
| Domain | FATC | 7.41e-04 | 6 | 133 | 2 | SM01343 | |
| Domain | Vinculin/catenin | 1.03e-03 | 7 | 133 | 2 | IPR006077 | |
| Domain | ZF_DAG_PE_1 | 1.12e-03 | 64 | 133 | 4 | PS00479 | |
| Domain | ZF_DAG_PE_2 | 1.12e-03 | 64 | 133 | 4 | PS50081 | |
| Domain | Spectrin_repeat | 1.13e-03 | 29 | 133 | 3 | IPR002017 | |
| Domain | C1 | 1.19e-03 | 65 | 133 | 4 | SM00109 | |
| Domain | PE/DAG-bd | 1.26e-03 | 66 | 133 | 4 | IPR002219 | |
| Domain | SPEC | 1.51e-03 | 32 | 133 | 3 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 1.51e-03 | 32 | 133 | 3 | IPR018159 | |
| Domain | Alpha_adaptinC2 | 1.75e-03 | 9 | 133 | 2 | PF02883 | |
| Domain | PG/BPGM_mutase_AS | 1.75e-03 | 9 | 133 | 2 | IPR001345 | |
| Domain | Clathrin_a/b/g-adaptin_app_Ig | 1.75e-03 | 9 | 133 | 2 | IPR008152 | |
| Domain | Alpha_adaptinC2 | 1.75e-03 | 9 | 133 | 2 | SM00809 | |
| Domain | Lipocln_cytosolic_FA-bd_dom | 1.80e-03 | 34 | 133 | 3 | IPR000566 | |
| Domain | Lipocalin | 1.80e-03 | 34 | 133 | 3 | PF00061 | |
| Domain | - | 1.96e-03 | 35 | 133 | 3 | 2.40.128.20 | |
| Domain | PGAM | 2.18e-03 | 10 | 133 | 2 | SM00855 | |
| Domain | PG_MUTASE | 2.18e-03 | 10 | 133 | 2 | PS00175 | |
| Domain | Calycin-like | 2.30e-03 | 37 | 133 | 3 | IPR011038 | |
| Domain | Calycin | 2.30e-03 | 37 | 133 | 3 | IPR012674 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 3.09e-03 | 138 | 133 | 5 | IPR001245 | |
| Domain | His_Pase_superF_clade-1 | 3.17e-03 | 12 | 133 | 2 | IPR013078 | |
| Domain | His_Phos_1 | 3.17e-03 | 12 | 133 | 2 | PF00300 | |
| Domain | Ser/Thr_kinase_AS | 4.08e-03 | 357 | 133 | 8 | IPR008271 | |
| Domain | P_typ_ATPase_c | 4.33e-03 | 14 | 133 | 2 | IPR032630 | |
| Domain | P-type_ATPase_N | 4.33e-03 | 14 | 133 | 2 | IPR032631 | |
| Domain | P-type_ATPase_IV | 4.33e-03 | 14 | 133 | 2 | IPR006539 | |
| Domain | IRS | 4.33e-03 | 14 | 133 | 2 | PF02174 | |
| Domain | IRS_PTB | 4.33e-03 | 14 | 133 | 2 | IPR002404 | |
| Domain | PhoLip_ATPase_C | 4.33e-03 | 14 | 133 | 2 | PF16212 | |
| Domain | PhoLip_ATPase_N | 4.33e-03 | 14 | 133 | 2 | PF16209 | |
| Domain | PROTEIN_KINASE_ST | 4.43e-03 | 362 | 133 | 8 | PS00108 | |
| Domain | Clathrin/coatomer_adapt-like_N | 4.97e-03 | 15 | 133 | 2 | IPR002553 | |
| Domain | Adaptin_N | 4.97e-03 | 15 | 133 | 2 | PF01602 | |
| Domain | TBC | 5.12e-03 | 49 | 133 | 3 | SM00164 | |
| Domain | - | 5.66e-03 | 16 | 133 | 2 | 1.10.1070.11 | |
| Domain | PI3Kc | 5.66e-03 | 16 | 133 | 2 | SM00146 | |
| Domain | RabGAP-TBC | 6.38e-03 | 53 | 133 | 3 | PF00566 | |
| Domain | LIPOCALIN | 6.38e-03 | 17 | 133 | 2 | PS00213 | |
| Domain | Rab-GTPase-TBC_dom | 7.07e-03 | 55 | 133 | 3 | IPR000195 | |
| Domain | TBC_RABGAP | 7.07e-03 | 55 | 133 | 3 | PS50086 | |
| Pathway | REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING | 7.19e-07 | 24 | 103 | 5 | M2243 | |
| Pathway | REACTOME_SEMAPHORIN_INTERACTIONS | 6.99e-06 | 64 | 103 | 6 | M7923 | |
| Pathway | REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE | 1.19e-05 | 20 | 103 | 4 | M18415 | |
| Pathway | REACTOME_SEMAPHORIN_INTERACTIONS | 3.40e-05 | 51 | 103 | 5 | MM14967 | |
| Pathway | REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING | 1.62e-04 | 15 | 103 | 3 | MM15037 | |
| Pubmed | 1.90e-12 | 21 | 143 | 7 | 16079250 | ||
| Pubmed | NBPF12 DGKD PFKFB2 PFKFB3 HNRNPUL1 NBPF11 NBPF1 NBPF15 IGF2BP1 DST NBPF9 SETBP1 NBPF10 HERC2 HSPA6 | 3.77e-09 | 513 | 143 | 15 | 25798074 | |
| Pubmed | VAPA GPD2 CUL2 GAK KIF23 COPG1 MCM2 UFL1 COPS3 PFKFB3 HNRNPUL1 ITPR3 EVI5 EEF1G IGF2BP1 DST PRRC2C TLN1 SYNE2 VPS35 ATM HSPA6 CNOT3 EVI5L | 5.24e-09 | 1440 | 143 | 24 | 30833792 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | KIF23 COPG1 NEK7 MCM2 DGKD SMARCAD1 COPS3 HNRNPUL1 MCM10 TRRAP LUZP1 EEF1G METTL13 DST AP1G1 MYH14 TLN1 VPS35 RTCA CCT6B HERC2 UTRN HSPA6 | 7.90e-09 | 1353 | 143 | 23 | 29467282 |
| Pubmed | GPD2 MICAL1 GAK LZTS3 PACSIN1 DOCK8 NCKIPSD COPS3 IDH3A TRIP11 LUZP1 NLGN3 EEF1G DST AP1G1 MYH14 PRRC2C TLN1 VPS35 FGA TLN2 UTRN DNAH11 | 2.22e-08 | 1431 | 143 | 23 | 37142655 | |
| Pubmed | Evolutionary history and genome organization of DUF1220 protein domains. | 5.64e-08 | 10 | 143 | 4 | 22973535 | |
| Pubmed | VAPA CUL2 GAK KIF23 COPG1 MCM2 UFL1 SMARCAD1 HNRNPUL1 TRRAP LUZP1 MET EEF1G METTL13 DST PRRC2C SYNE2 CDYL RAB21 HSPA6 CNOT3 | 8.63e-08 | 1297 | 143 | 21 | 33545068 | |
| Pubmed | VAPA GAK COPG1 UFL1 RABGAP1 TRIP11 LUZP1 ITPR3 DST ODR4 PRRC2C TLN1 SYNE2 PDCL | 1.06e-07 | 568 | 143 | 14 | 37774976 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | VAPA GAK ERCC5 LEO1 NEK7 ACVR1B TRRAP LUZP1 MET KSR1 LIMK1 DST NRK TLN1 MAP3K13 UTRN PCDH18 | 2.28e-07 | 910 | 143 | 17 | 36736316 |
| Pubmed | 2.68e-07 | 64 | 143 | 6 | 26511642 | ||
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | VAPA GPD2 CUL2 DOCK8 NCKIPSD TRRAP RAB3C EEF1G DST AP1G1 SETBP1 VPS35 CCT6B ROCK1 | 3.11e-07 | 621 | 143 | 14 | 22794259 |
| Pubmed | GAK TRIP11 LUZP1 ITPR3 MET EEF1G DST PRRC2C TLN1 UTRN CAVIN2 | 3.21e-07 | 360 | 143 | 11 | 33111431 | |
| Pubmed | SIKE1 FGFR1OP2 MTMR12 DOCK8 IFFO1 NCKIPSD CCDC85C PFKFB2 LUZP1 KSR1 DST UTRN | 3.57e-07 | 446 | 143 | 12 | 24255178 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | VAPA GPD2 ERCC5 LEO1 COPG1 MAT2B MCM2 UFL1 SMARCAD1 HNRNPUL1 NOSIP EEF1G IGF2BP1 AP1G1 PRRC2C FRG1 TLN1 SYNE2 VPS35 HSPA6 SPINK5 | 3.63e-07 | 1415 | 143 | 21 | 28515276 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | VAPA GPD2 KIF23 ATP8B4 COPG1 MAT2B MCM2 UFL1 SMARCAD1 COPS3 IDH3A HNRNPUL1 EEF1G IGF2BP1 METTL13 AP1G1 MYH14 TLN1 VPS35 TLN2 ATM | 4.07e-07 | 1425 | 143 | 21 | 30948266 |
| Pubmed | GPD2 MTMR12 ERCC5 PFKFB2 PFKFB3 EVI5 ODR4 VPS35 ROCK1 HSPA6 CNOT3 | 5.19e-07 | 378 | 143 | 11 | 34315543 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | MTMR12 KIF23 NCKIPSD CCDC85C PFKFB2 HNRNPUL1 TRIP11 LUZP1 KSR1 LIMK1 DST PRRC2C SYNE2 PDCL RAB21 UTRN | 5.68e-07 | 861 | 143 | 16 | 36931259 |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | VAPA CUL2 FGFR1OP2 COPG1 MCM2 COPS3 IDH3A TRRAP FABP4 UCHL3 FRG1 VPS35 RTCA CHMP3 HERC2 SCLT1 UTRN | 9.00e-07 | 1005 | 143 | 17 | 19615732 |
| Pubmed | Scanning the human proteome for calmodulin-binding proteins. | 2.32e-06 | 92 | 143 | 6 | 15840729 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | VAPA LEO1 MCM2 RABGAP1 CCDC144CP IDH3A EEF1G IGF2BP1 MYH14 PRRC2C TLN1 ROCK1 TLN2 UTRN HSPA6 | 2.36e-06 | 847 | 143 | 15 | 35235311 |
| Pubmed | The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1. | 2.93e-06 | 212 | 143 | 8 | 33853758 | |
| Pubmed | LEO1 COPG1 CMC1 MCM2 UFL1 IDH3A NOSIP EEF1G AP1G1 FRG1 TLN1 VPS35 ROCK1 | 3.29e-06 | 653 | 143 | 13 | 33742100 | |
| Pubmed | KIF23 COPG1 HNRNPUL1 TRRAP ITPR3 DST MYH14 PRRC2C TLN1 SYNE2 ATM HERC2 UTRN | 3.29e-06 | 653 | 143 | 13 | 22586326 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | CDO1 KIF23 ERCC5 LEO1 RBBP8 MCM2 UFL1 SMARCAD1 HNRNPUL1 TRRAP URGCP TLN2 ATM CNOT3 | 4.10e-06 | 774 | 143 | 14 | 15302935 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | GPD2 MCM2 UFL1 IDH3A HNRNPUL1 TRRAP ITPR3 EEF1G IGF2BP1 DST MYH14 TLN1 SYNE2 HERC2 RAB21 UTRN | 5.28e-06 | 1024 | 143 | 16 | 24711643 |
| Pubmed | FGFR1OP2 LEO1 SMARCAD1 HNRNPUL1 TRIP11 LIMK1 ACAD8 DST MYH14 CEP70 CHMP3 TLN2 NR1H2 JAKMIP1 ATM HERC2 UTRN CNOT3 | 5.95e-06 | 1285 | 143 | 18 | 35914814 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | GAK LEO1 RBBP8 SMARCAD1 RABGAP1 TRIP11 LUZP1 NOSIP PRRC2C ROCK1 POTEJ CNOT3 | 6.22e-06 | 588 | 143 | 12 | 38580884 |
| Pubmed | Why do cellular proteins linked to K63-polyubiquitin chains not associate with proteasomes? | 7.05e-06 | 170 | 143 | 7 | 23314748 | |
| Pubmed | VAPA ERCC5 CCDC185 LEO1 RBBP8 RAB3C LUZP1 DST MYH14 PRRC2C SYNE2 VPS35 JAKMIP1 ATM POTEJ RAB21 TUBD1 HSPA6 CAVIN2 | 7.67e-06 | 1442 | 143 | 19 | 35575683 | |
| Pubmed | GPD2 MAT2B UFL1 PFKFB3 ITPR3 MET MYH14 ODR4 FGA JAKMIP1 CAVIN2 | 8.07e-06 | 503 | 143 | 11 | 36217030 | |
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | VAPA COPG1 MCM2 IDH3A HNRNPUL1 IGF2BP1 MYH14 PRRC2C TLN1 VPS35 FGA RAB21 | 8.55e-06 | 607 | 143 | 12 | 39147351 |
| Pubmed | VAPA COPG1 MAT2B MCM2 HNRNPUL1 NOSIP EEF1G DST MYH14 TLN1 CCT6B RAB21 UTRN HSPA6 | 1.09e-05 | 844 | 143 | 14 | 25963833 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | VAPA GPD2 CUL2 KIF23 COPG1 COPS3 RABGAP1 PFKFB3 IDH3A HNRNPUL1 NOSIP EEF1G AP1G1 TLN1 SYNE2 RTCA ROCK1 UTRN | 1.37e-05 | 1367 | 143 | 18 | 32687490 |
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 28986474 | ||
| Pubmed | Splice isoforms of ubiquitous 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase in human brain. | 1.68e-05 | 2 | 143 | 2 | 11245921 | |
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 26772622 | ||
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 10607840 | ||
| Pubmed | Expression of CYP3A4 and CYP3A7 in Human Foetal Tissues and its Correlation with Nuclear Receptors. | 1.68e-05 | 2 | 143 | 2 | 25689036 | |
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 27349315 | ||
| Pubmed | ROCK1 via LIM kinase regulates growth, maturation and actin based functions in mast cells. | 1.68e-05 | 2 | 143 | 2 | 26943578 | |
| Pubmed | CtIP protein dimerization is critical for its recruitment to chromosomal DNA double-stranded breaks. | 1.68e-05 | 2 | 143 | 2 | 22544744 | |
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 7700633 | ||
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 12588996 | ||
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 19940359 | ||
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 26822056 | ||
| Pubmed | Extracellular rigidity sensing by talin isoform-specific mechanical linkages. | 1.68e-05 | 2 | 143 | 2 | 26523364 | |
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 12044155 | ||
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 38813509 | ||
| Pubmed | Differential regulation of CYP3A4 and CYP3A7 by dimethylsulfoxide in primary human hepatocytes. | 1.68e-05 | 2 | 143 | 2 | 15379787 | |
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 17991424 | ||
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 26026086 | ||
| Pubmed | ROCK1 and LIM kinase modulate retrovirus particle release and cell-cell transmission events. | 1.68e-05 | 2 | 143 | 2 | 24696479 | |
| Pubmed | Role of Chromatin Structural Changes in Regulating Human CYP3A Ontogeny. | 1.68e-05 | 2 | 143 | 2 | 26921389 | |
| Pubmed | Molecular mechanisms of polymorphic CYP3A7 expression in adult human liver and intestine. | 1.68e-05 | 2 | 143 | 2 | 11940601 | |
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 20164843 | ||
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 22306379 | ||
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 23669355 | ||
| Pubmed | MCM10 overexpression implicates adverse prognosis in urothelial carcinoma. | 1.68e-05 | 2 | 143 | 2 | 27780919 | |
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 11864598 | ||
| Pubmed | Developmental regulation of CYP3A4 and CYP3A7 in Chinese Han population. | 1.68e-05 | 2 | 143 | 2 | 27727071 | |
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 12485945 | ||
| Pubmed | KIF23 COPG1 ACVR1B HNRNPUL1 MCM10 TRIP11 RAB3C MET EEF1G IGF2BP1 DST SCLT1 RAB21 | 2.09e-05 | 777 | 143 | 13 | 35844135 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | CUL2 CDO1 KIF23 COPG1 NEK7 UFL1 COPS3 PFKFB3 HNRNPUL1 TRRAP FABP4 MET IGF2BP1 METTL13 VPS35 RTCA HERC2 | 2.26e-05 | 1284 | 143 | 17 | 17353931 |
| Pubmed | 3.09e-05 | 87 | 143 | 5 | 17979178 | ||
| Pubmed | DOCK8 HNRNPUL1 GGA3 EEF1G DST AP1G1 VPS35 CHMP3 ROCK1 HERC2 UTRN | 3.56e-05 | 591 | 143 | 11 | 15231748 | |
| Pubmed | 4.29e-05 | 225 | 143 | 7 | 12168954 | ||
| Pubmed | KIF23 LZTS3 TRIP11 RAB3C LUZP1 NOSIP NLGN3 DST PRRC2C SYNE2 ROCK1 TLN2 JAKMIP1 HERC2 | 4.63e-05 | 963 | 143 | 14 | 28671696 | |
| Pubmed | 4.95e-05 | 506 | 143 | 10 | 30890647 | ||
| Pubmed | Type I gamma phosphatidylinositol phosphate kinase targets and regulates focal adhesions. | 5.02e-05 | 3 | 143 | 2 | 12422220 | |
| Pubmed | 5.02e-05 | 3 | 143 | 2 | 14623077 | ||
| Pubmed | Possible pheromone-carrier function of two lipocalin proteins in the vomeronasal organ. | 5.02e-05 | 3 | 143 | 2 | 7813422 | |
| Pubmed | 5.02e-05 | 3 | 143 | 2 | 30886146 | ||
| Pubmed | 5.02e-05 | 3 | 143 | 2 | 19801957 | ||
| Pubmed | 5.02e-05 | 3 | 143 | 2 | 20621111 | ||
| Pubmed | Functional link of BRCA1 and ataxia telangiectasia gene product in DNA damage response. | 5.02e-05 | 3 | 143 | 2 | 10910365 | |
| Pubmed | ROCK1 but not LIMK1 or PAK2 is a key regulator of apoptotic membrane blebbing and cell disassembly. | 5.02e-05 | 3 | 143 | 2 | 31043701 | |
| Pubmed | 5.02e-05 | 3 | 143 | 2 | 26592241 | ||
| Pubmed | Sema4D induces angiogenesis through Met recruitment by Plexin B1. | 5.02e-05 | 3 | 143 | 2 | 15632204 | |
| Pubmed | 5.02e-05 | 3 | 143 | 2 | 18792400 | ||
| Pubmed | 5.02e-05 | 3 | 143 | 2 | 22665520 | ||
| Pubmed | 5.02e-05 | 3 | 143 | 2 | 17396233 | ||
| Pubmed | An essential role for talin during alpha(M)beta(2)-mediated phagocytosis. | 5.02e-05 | 3 | 143 | 2 | 17202407 | |
| Pubmed | The semaphorin 4D receptor controls invasive growth by coupling with Met. | 5.02e-05 | 3 | 143 | 2 | 12198496 | |
| Pubmed | 5.02e-05 | 3 | 143 | 2 | 20118548 | ||
| Pubmed | ATM-dependent MiR-335 targets CtIP and modulates the DNA damage response. | 5.02e-05 | 3 | 143 | 2 | 23696749 | |
| Pubmed | 5.02e-05 | 3 | 143 | 2 | 11689934 | ||
| Pubmed | 5.02e-05 | 3 | 143 | 2 | 30819197 | ||
| Pubmed | ATM and MET kinases are synthetic lethal with nongenotoxic activation of p53. | 5.02e-05 | 3 | 143 | 2 | 22660439 | |
| Pubmed | Prognostic significance of minichromosome maintenance mRNA expression in human lung adenocarcinoma. | 5.02e-05 | 3 | 143 | 2 | 31545501 | |
| Pubmed | Regulation of the actin cytoskeleton by Rho kinase controls antigen presentation by CD1d. | 5.02e-05 | 3 | 143 | 2 | 22798677 | |
| Pubmed | 5.02e-05 | 3 | 143 | 2 | 23468639 | ||
| Pubmed | Mechanotransduction in talin through the interaction of the R8 domain with DLC1. | 5.02e-05 | 3 | 143 | 2 | 30028837 | |
| Pubmed | 5.02e-05 | 3 | 143 | 2 | 33097710 | ||
| Pubmed | Metabolic pathways of inhaled glucocorticoids by the CYP3A enzymes. | 5.02e-05 | 3 | 143 | 2 | 23143891 | |
| Pubmed | 5.02e-05 | 3 | 143 | 2 | 33866277 | ||
| Pubmed | 5.02e-05 | 3 | 143 | 2 | 21664574 | ||
| Pubmed | 5.02e-05 | 3 | 143 | 2 | 19952892 | ||
| Pubmed | Contribution of three CYP3A isoforms to metabolism of R- and S-warfarin. | 5.02e-05 | 3 | 143 | 2 | 20615193 | |
| Pubmed | 5.02e-05 | 3 | 143 | 2 | 22277676 | ||
| Pubmed | 5.02e-05 | 3 | 143 | 2 | 19160486 | ||
| GeneFamily | Neuroblastoma breakpoint family | 1.27e-11 | 23 | 89 | 7 | 662 | |
| GeneFamily | 6-phosphofructo-2-kinases/fructose-2,6-biphosphatases | 1.43e-04 | 4 | 89 | 2 | 1077 | |
| GeneFamily | Cytochrome P450 family 3 | 6.58e-04 | 8 | 89 | 2 | 1002 | |
| GeneFamily | ATPase phospholipid transporting | 2.41e-03 | 15 | 89 | 2 | 1210 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 3.48e-03 | 18 | 89 | 2 | 91 | |
| GeneFamily | Lipocalins | 3.88e-03 | 19 | 89 | 2 | 631 | |
| GeneFamily | Protein phosphatase catalytic subunits|STRIPAK complex | 4.30e-03 | 20 | 89 | 2 | 1371 | |
| Coexpression | GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_IMMATURE_NEURON_CELL_LINE_UP | 1.62e-06 | 200 | 143 | 9 | M7427 | |
| Coexpression | GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS | VAPA ATP8B4 RBBP8 MCM2 COPS3 IDH3A ARMC1 NOSIP MET SLC7A1 METTL13 ACAD8 MYH14 FRG1 SETBP1 CDYL HERC2 TRIM44 SLC16A10 | 2.59e-06 | 1009 | 143 | 19 | M157 |
| Coexpression | PUJANA_BRCA2_PCC_NETWORK | KIF23 RBBP8 MCM2 COPS3 HNRNPUL1 TRRAP SLC7A1 FRG1 RTCA LEF1 CNOT3 VAV1 | 4.07e-06 | 426 | 143 | 12 | M9516 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | CUL2 KIF23 NEK7 ATP8B1 RABGAP1 TRRAP SNX13 EVI5 SLC7A1 DST PRRC2C SYNE2 ROCK1 CDYL RAB21 TRIM44 | 1.86e-05 | 856 | 143 | 16 | M4500 |
| Coexpression | GSE40274_CTRL_VS_FOXP3_AND_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN | 3.25e-05 | 163 | 143 | 7 | M9115 | |
| Coexpression | PUJANA_XPRSS_INT_NETWORK | 3.95e-05 | 168 | 143 | 7 | M18811 | |
| Coexpression | PUJANA_BRCA_CENTERED_NETWORK | 4.74e-05 | 118 | 143 | 6 | M15305 | |
| Coexpression | MURARO_PANCREAS_BETA_CELL | RBBP8 DGKD PFKFB2 ACVR1B SCGN TRIP11 CDC37L1 ITPR3 SLC7A1 DST MYH14 SETBP1 SYNE2 VPS35 ROCK1 UTRN | 6.16e-05 | 946 | 143 | 16 | M39169 |
| Coexpression | GSE38696_LIGHT_ZONE_VS_DARK_ZONE_BCELL_UP | 7.02e-05 | 184 | 143 | 7 | M9005 | |
| Coexpression | CUI_DEVELOPING_HEART_CORONARY_VASCULAR_ENDOTHELIAL_CELL | 7.35e-05 | 41 | 143 | 4 | M39320 | |
| Coexpression | GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_DC_DN | 1.08e-04 | 197 | 143 | 7 | M5210 | |
| Coexpression | GSE17721_POLYIC_VS_GARDIQUIMOD_24H_BMDC_DN | 1.14e-04 | 199 | 143 | 7 | M4036 | |
| Coexpression | GSE7852_TREG_VS_TCONV_THYMUS_DN | 1.14e-04 | 199 | 143 | 7 | M5732 | |
| Coexpression | GSE17721_CTRL_VS_CPG_1H_BMDC_UP | 1.18e-04 | 200 | 143 | 7 | M3756 | |
| Coexpression | GSE360_DC_VS_MAC_L_DONOVANI_UP | 1.18e-04 | 200 | 143 | 7 | M5174 | |
| Coexpression | GSE40068_CXCR5POS_BCL6POS_TFH_VS_CXCR5NEG_BCL6NEG_CD4_TCELL_DN | 1.18e-04 | 200 | 143 | 7 | M9262 | |
| Coexpression | GSE12845_IGD_POS_BLOOD_VS_PRE_GC_TONSIL_BCELL_DN | 1.18e-04 | 200 | 143 | 7 | M3188 | |
| Coexpression | LI_ADIPOGENESIS_BY_ACTIVATED_PPARG | 1.22e-04 | 18 | 143 | 3 | M1645 | |
| Coexpression | LI_ADIPOGENESIS_BY_ACTIVATED_PPARG | 1.45e-04 | 19 | 143 | 3 | MM1202 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_Urothelium_emap-28091_top-relative-expression-ranked_1000 | VAPA CDO1 DOCK8 RBBP8 ZBTB8B CLEC1A DGKD ATP8B1 RABGAP1 FABP4 MET DST VPS35 JAKMIP1 HERC2 UTRN PLXNB1 | 1.37e-05 | 784 | 138 | 17 | gudmap_developingLowerUrinaryTract_e15.5_urothelium_1000 |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.43e-07 | 183 | 143 | 8 | 3427f3cbe6ea81709750e7dd3ff378f03ae65eab | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.69e-07 | 187 | 143 | 8 | 0099def970fbc828756fbf853eca2ce77b8cd342 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.15e-07 | 193 | 143 | 8 | 58c590dd6f21bc7ae58ae1729dd574c0f1069592 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.12e-06 | 166 | 143 | 7 | 7a45785a40b7425f97be67bab1c5ceb69b2bd85a | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.12e-06 | 166 | 143 | 7 | bbd382812f8a84a5d99888de2d7cca3a8b5e4695 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Mesenchymal-Unfolded_protein_responsible_cell|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 1.29e-06 | 107 | 143 | 6 | 7fee0193ee02e9cc62f506660ea7ec23fb4d0c84 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.23e-06 | 184 | 143 | 7 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-EECs|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.31e-06 | 185 | 143 | 7 | d42f6722a6771752cd744146a09e2ead9b7252bc | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.86e-06 | 191 | 143 | 7 | b270c3dd5952f56b9bdceabe13e298fe6757563b | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.96e-06 | 192 | 143 | 7 | 285a9d332a1e07b94f222d4b518dd56928b9e075 | |
| ToppCell | severe-pDC|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.63e-06 | 198 | 143 | 7 | 22da4a29b9ff8b94d98bc69b4632a2a58d5dd9e6 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.87e-06 | 200 | 143 | 7 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | 5.65e-06 | 138 | 143 | 6 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.36e-05 | 161 | 143 | 6 | f4f5d6eaa32169de699c8ff8e8ae35179c8e25c0 | |
| ToppCell | Control-B_intermediate-1|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.68e-05 | 167 | 143 | 6 | 948504367ecf58144d9dd74d2ec531358fc4b309 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_SEMA6D|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.05e-05 | 173 | 143 | 6 | 9a2d42f8d9cb834856522661d524abb91c4637c5 | |
| ToppCell | metastatic_Brain-Endothelial_cells-Stalk-like_ECs|Endothelial_cells / Location, Cell class and cell subclass | 2.18e-05 | 175 | 143 | 6 | f6a6db992e803d36c866a91706b02f67e0fd3e09 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Endothelial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.33e-05 | 177 | 143 | 6 | ca5a30b3e7bcfdd8de01ceaf7449735b5cd503af | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Endothelial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.33e-05 | 177 | 143 | 6 | f471f7747d6e8db7546899019af9508f48a14f89 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Endothelial-endothelial_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.33e-05 | 177 | 143 | 6 | cd0684b876c2a7d5fe7e2773e8e25bb61ecbc795 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-05 | 178 | 143 | 6 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | facs-Diaphragm-Limb_Muscle-18m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-05 | 178 | 143 | 6 | 40bd605b801d9ae76cffc8f62836092fc2b06812 | |
| ToppCell | COVID-19_Convalescent-PLT_1|World / Disease Group and Platelet Clusters | 2.48e-05 | 179 | 143 | 6 | d0f2764c6fc5d61fd69e9231b3603a80ac373f65 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.64e-05 | 181 | 143 | 6 | 4d7793026373cbcf04b15c77f95f1025d07d4c00 | |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial_progenitor-epi-tip_intermediate|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.98e-05 | 185 | 143 | 6 | 636505a3d96f75d951ab42bcf8af6ae07abc732d | |
| ToppCell | droplet-Heart-nan-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.08e-05 | 186 | 143 | 6 | 0ae5fbe9f210cb25092394267e1d3d6ed05627b8 | |
| ToppCell | COVID-19_Severe-pDC-|COVID-19_Severe / Disease condition and Cell class | 3.27e-05 | 188 | 143 | 6 | 9fd1116e31a05554850b8ed3c005ea660dfbd51c | |
| ToppCell | droplet-Kidney-nan-3m-Endothelial-kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.27e-05 | 188 | 143 | 6 | 67c04f446fa4528b13a381622e88eb1f314cc6d5 | |
| ToppCell | droplet-Kidney-nan-3m-Endothelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.27e-05 | 188 | 143 | 6 | 03a7f6538cfddc230c0eab10c3613929addd7e33 | |
| ToppCell | COVID-19_Severe-pDC|COVID-19_Severe / Disease condition and Cell class | 3.27e-05 | 188 | 143 | 6 | 475008f45673b42b75ef231c2df91f8b9adc9201 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.46e-05 | 190 | 143 | 6 | d87b9e9ca863270a9c7f61674271a6440c97d1f4 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.57e-05 | 191 | 143 | 6 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | (011)_pDC|World / immune cells in Peripheral Blood (logTPM normalization) | 3.57e-05 | 191 | 143 | 6 | d82ac4f6d9863734e09bf3cb71c1354a49b66b4f | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.57e-05 | 191 | 143 | 6 | f76f3f5c7902a3659d8cbe470f96ce57c8a6744d | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.57e-05 | 191 | 143 | 6 | 27f23c2254b610abac1a88d0fecff305addde9da | |
| ToppCell | P07-Endothelial-large_vessel_endothelial_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.57e-05 | 191 | 143 | 6 | d162917816dd2e4767c97447c1cddae9397713ab | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.57e-05 | 191 | 143 | 6 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_DC-DC-pDC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.78e-05 | 193 | 143 | 6 | 2c35aadc397e7e365c3daf8017ae1d3bd045f305 | |
| ToppCell | Control-Myeloid-ncMonocyte|Myeloid / Disease state, Lineage and Cell class | 3.78e-05 | 193 | 143 | 6 | 3479c01aaae7afd7e02d00e0cb21951c0106a0fd | |
| ToppCell | VE-pDC-|VE / Condition, Cell_class and T cell subcluster | 3.78e-05 | 193 | 143 | 6 | 583724de588fcde3aeda056138c522dc0225a387 | |
| ToppCell | VE-pDC|VE / Condition, Cell_class and T cell subcluster | 3.78e-05 | 193 | 143 | 6 | bb759dc9ef0ec41d655002f59021d62d62d44289 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.89e-05 | 194 | 143 | 6 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | Control-Myeloid-ncMonocyte|Control / Disease state, Lineage and Cell class | 4.01e-05 | 195 | 143 | 6 | fcb05948e7480dc53f06f3fc9b9c3fc129874edd | |
| ToppCell | Control-Myeloid-ncMonocyte|World / Disease state, Lineage and Cell class | 4.01e-05 | 195 | 143 | 6 | b4444b67a709e82b8e2ee510924c3152cb88b051 | |
| ToppCell | mild-pDC|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.24e-05 | 197 | 143 | 6 | 0cb00daa6943f7a7fb34a8fdf51188646af65686 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.36e-05 | 198 | 143 | 6 | 24f6954aff8751885e783d68c631b04dd1980f48 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.36e-05 | 198 | 143 | 6 | 4633e379893a26a746f8e29302cc54bbe04dd23f | |
| ToppCell | severe-pDC|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.36e-05 | 198 | 143 | 6 | 3c4820a8391088682fb3e47b914f872533bae227 | |
| ToppCell | COVID-19_Convalescent-Lymphoid_T/NK|COVID-19_Convalescent / Disease group, lineage and cell class | 4.36e-05 | 198 | 143 | 6 | 457ba9e3f1bb6453af8cc1a6e7436af66296f8f5 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 4.48e-05 | 199 | 143 | 6 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | (05)_Secretory-(2)_GFP_FOXI1|(05)_Secretory / shred by cell type by condition | 4.48e-05 | 199 | 143 | 6 | d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-A_(Artery)|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.48e-05 | 199 | 143 | 6 | 29ed081bd5204a32068b420f2244f3704891547b | |
| ToppCell | 367C-Endothelial_cells-Endothelial-A_(Artery)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.48e-05 | 199 | 143 | 6 | c2d85f80037f209a4a329790f475d9f98f590262 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-dn_T|COVID-19_Mild / Disease, condition lineage and cell class | 4.48e-05 | 199 | 143 | 6 | f307d4887b28cf60a591439e278fd668409cb104 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-dn_T|Control / Disease, condition lineage and cell class | 4.61e-05 | 200 | 143 | 6 | 10882c59b7aaf8bd4b5c00aa4ddbb9f7ac5b2cf5 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-A_(Artery)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.61e-05 | 200 | 143 | 6 | 50b8788494b744e0f0ec8c4d67a1c90ae09dca65 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-A_(Artery)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.61e-05 | 200 | 143 | 6 | f5f24273bee3259a4a3be99ba53b88defa1286c0 | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-immature_Neutrophil-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.55e-05 | 142 | 143 | 5 | e160f35b3c18e77c4107fe96db5f56227c91785e | |
| ToppCell | Mild/Remission-B_naive-1|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 9.87e-05 | 143 | 143 | 5 | bd3f5fbd4e9e4dc414682db5607494f3ce988deb | |
| ToppCell | Control-B_intermediate-1|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.02e-04 | 144 | 143 | 5 | 984470ff6ddce4c743e2db78fa98dae055aaa273 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_2|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.05e-04 | 145 | 143 | 5 | 734d85ca7a2e5e040f433cadc5f9be1f25cf2e91 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_2|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.05e-04 | 145 | 143 | 5 | 8ba09eb0fd27f25aa90a3ad75d67a9f79f3f4f43 | |
| ToppCell | ICU-SEP-Lymphocyte-T_NK-CD8_Naive|ICU-SEP / Disease, Lineage and Cell Type | 1.20e-04 | 149 | 143 | 5 | a66f3ebf6214b269b137ddd5f4d8d7fb3ef2d962 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_B-GC_B_(II)|lymph-node_spleen / Manually curated celltypes from each tissue | 1.31e-04 | 152 | 143 | 5 | 4f690aed23338687bdefc47e8a2f3d1fdb2b6447 | |
| ToppCell | E15.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.40e-04 | 154 | 143 | 5 | e65e4636646164610f33f7bbac0d879a3ea55986 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c09-SLC4A10|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.40e-04 | 154 | 143 | 5 | e94cd11488003347120eacd3ced0a8923ed09ccc | |
| ToppCell | severe_influenza-CD8+_T_naive|severe_influenza / disease group, cell group and cell class (v2) | 1.72e-04 | 161 | 143 | 5 | 82196139cdbbd70a36957a87bc9ac6d02575da3f | |
| ToppCell | normal-na-Lymphocytic_NK-NK_bright-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.87e-04 | 164 | 143 | 5 | b5a91f2cbfad9a2bc38aea576085a37865df955d | |
| ToppCell | LV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 1.93e-04 | 165 | 143 | 5 | f37fd95adc95d7753cf6e55ae819976513c7ec77 | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-Zbtb32+_B|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-04 | 166 | 143 | 5 | 3e3e9296e6919a38602e417a6606c046af3bd101 | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-Zbtb32+_B_cell-Zbtb32+_B_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.04e-04 | 167 | 143 | 5 | 3c3e1c31aacca48099693aea2efdfa22fc0e4af4 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.04e-04 | 167 | 143 | 5 | cb650f74306fa0d9f4bf49890b73065d193b94dc | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-Zbtb32+_B_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.04e-04 | 167 | 143 | 5 | 77a4d7ce44847c76074d4f5340d61b398fe43e6c | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CD4-positive,_alpha-beta_T_cell-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.10e-04 | 168 | 143 | 5 | 5e721268f0baa51d3f640f7f4c41db769ebef210 | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l5|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.15e-04 | 169 | 143 | 5 | a388e53deac861a185c31e9cceddae7bcb344700 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_dendritic-CD1c-positive_myeloid_dendritic_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.21e-04 | 170 | 143 | 5 | cc66ac6846c58be9493eb270644ee3ce0f86cfea | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Lymphocytic-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-04 | 170 | 143 | 5 | 3ad9f950b87ee98f025ab9b4a8ed551e6a9b4764 | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-Developping_Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.27e-04 | 171 | 143 | 5 | 13126a3fbee181412c13ffb0c347277b9d8f16f7 | |
| ToppCell | COVID_vent-Lymphocytic-Dendritic-pDC|COVID_vent / Disease condition, Lineage, Cell class and subclass | 2.27e-04 | 171 | 143 | 5 | 779c951d274ecbd1d546ac425d6c8e718623be5a | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 2.27e-04 | 171 | 143 | 5 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | COVID_vent-Lymphocytic-Dendritic|COVID_vent / Disease condition, Lineage, Cell class and subclass | 2.27e-04 | 171 | 143 | 5 | debbb071d260639b16269c94d172766908325c58 | |
| ToppCell | E15.5-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_vein|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.27e-04 | 171 | 143 | 5 | 3112d15f2a28cf4a71992db4971d960716dc1264 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-pDC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.34e-04 | 172 | 143 | 5 | b84610f1e5889a655652800c2b3270d264bfe1a9 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.34e-04 | 172 | 143 | 5 | 8a6a2b4c6654bc976e60a02d0e7303a9071ed55f | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.40e-04 | 173 | 143 | 5 | 20f7dfe7d92a3dbec9da9a1f3185aa10cb8f0a3c | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.40e-04 | 173 | 143 | 5 | 8ac2e9d39c0f76e674f8bd59d1da246bab4867c8 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD8-Tnaive/CM_CD8|Liver / Manually curated celltypes from each tissue | 2.47e-04 | 174 | 143 | 5 | 03918ca51ae3b4c9c1a74769b08ea23f518286ba | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.47e-04 | 174 | 143 | 5 | b3cd22e717d178269e6d5bd5ed7b2d945cd8ea25 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.47e-04 | 174 | 143 | 5 | ae363ce736fc8af439f3ad594d7bc2e344db80d4 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.53e-04 | 175 | 143 | 5 | 1b4cefae400bf756d09ece32d3f5c0bd4c6ad73f | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_CD56bright-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.53e-04 | 175 | 143 | 5 | 0ed053aa8353c72ff37fee830672704a3ddc7d85 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_CD56bright|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.53e-04 | 175 | 143 | 5 | 0124a3c4696b39cee8b566e94603d1d3d128bfa5 | |
| ToppCell | BAL-Control-cDC_11|Control / Compartment, Disease Groups and Clusters | 2.53e-04 | 175 | 143 | 5 | daf014e15a354956e9149c83fd89d0af0d07eb00 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_CD56bright|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.53e-04 | 175 | 143 | 5 | e219b61d6bc078d44ea7d06191d3462654d857a1 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_CD56bright-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.53e-04 | 175 | 143 | 5 | bd16c80418bf71127e6f1e50edf83967c9218b42 | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-GrB-secreting_B_cells|normal_Lymph_Node / Location, Cell class and cell subclass | 2.53e-04 | 175 | 143 | 5 | 29fbdfe1d3bfcb063be2bced0128a33176c5b78f | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-pDCs|normal_Lymph_Node / Location, Cell class and cell subclass | 2.60e-04 | 176 | 143 | 5 | 476794ef75ce5ab732d78cfeb4944e2f841e3e92 | |
| ToppCell | B_cells-pDCs|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 2.60e-04 | 176 | 143 | 5 | ce757de9e09a225f3f96433f103f43619b0e0dda | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-CD8+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.60e-04 | 176 | 143 | 5 | 4478b3284201220e902bd2077960dc0d4d4a2c7c | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-GrB-secreting_B_cells|B_lymphocytes / Location, Cell class and cell subclass | 2.60e-04 | 176 | 143 | 5 | d6e660df92a3d7dd5732171ee623763faf108476 | |
| Drug | Pesticides | 4.10e-07 | 150 | 141 | 9 | ctd:D010575 | |
| Disease | tacrolimus measurement | 1.26e-04 | 4 | 136 | 2 | EFO_0008458 | |
| Disease | estrone conjugate measurement | 1.26e-04 | 4 | 136 | 2 | EFO_0007971 | |
| Disease | tauro-beta-muricholate measurement | 2.09e-04 | 5 | 136 | 2 | EFO_0800213 | |
| Disease | glyco-beta-muricholate measurement | 2.09e-04 | 5 | 136 | 2 | EFO_0800569 | |
| Disease | odorant-binding protein 2b measurement | 2.09e-04 | 5 | 136 | 2 | EFO_0801859 | |
| Disease | stem Cell Growth Factor-beta measurement | 2.09e-04 | 5 | 136 | 2 | EFO_0802090 | |
| Disease | dehydroisoandrosterone sulfate DHEA-S measurement | 3.13e-04 | 6 | 136 | 2 | EFO_0021119 | |
| Disease | androstenediol (3beta,17beta) monosulfate (1) measurement | 3.13e-04 | 6 | 136 | 2 | EFO_0800294 | |
| Disease | X-24574 measurement | 4.36e-04 | 7 | 136 | 2 | EFO_0800897 | |
| Disease | Malignant neoplasm of breast | MICAL1 CYP3A4 ATP8B1 FABP4 GGA3 KCNH1 SETBP1 SYNE2 MAP3K13 ATM HERC2 LEF1 DNASE1L3 PLXNB1 | 4.54e-04 | 1074 | 136 | 14 | C0006142 |
| Disease | androstenediol (3beta,17beta) disulfate (1) measurement | 7.43e-04 | 9 | 136 | 2 | EFO_0800278 | |
| Disease | nevus count, cutaneous melanoma | 8.46e-04 | 91 | 136 | 4 | EFO_0000389, EFO_0004632 | |
| Disease | Neurodevelopmental Disorders | 9.18e-04 | 93 | 136 | 4 | C1535926 | |
| Disease | 4-androsten-3alpha,17alpha-diol monosulfate (3) measurement | 9.26e-04 | 10 | 136 | 2 | EFO_0022090 | |
| Disease | 5alpha-androstan-3beta,17alpha-diol disulfate measurement | 9.26e-04 | 10 | 136 | 2 | EFO_0800289 | |
| Disease | Adenocarcinoma of large intestine | 1.03e-03 | 96 | 136 | 4 | C1319315 | |
| Disease | DNA repair protein RAD51 homolog 4 measurement | 1.13e-03 | 11 | 136 | 2 | EFO_0801531 | |
| Disease | androstenediol (3beta,17beta) monosulfate (2) measurement | 1.13e-03 | 11 | 136 | 2 | EFO_0800295 | |
| Disease | Osteosarcoma | 1.34e-03 | 47 | 136 | 3 | C0029463 | |
| Disease | response to diuretic, high density lipoprotein cholesterol measurement | 1.35e-03 | 12 | 136 | 2 | EFO_0004612, GO_0036270 | |
| Disease | 5alpha-androstan-3beta,17beta-diol monosulfate (2) measurement | 1.35e-03 | 12 | 136 | 2 | EFO_0800291 | |
| Disease | androstenediol (3alpha, 17alpha) monosulfate (3) measurement | 1.59e-03 | 13 | 136 | 2 | EFO_0800293 | |
| Disease | 5alpha-pregnan-3beta,20beta-diol monosulfate (1) measurement | 1.59e-03 | 13 | 136 | 2 | EFO_0800284 | |
| Disease | X-21470 measurement | 1.85e-03 | 14 | 136 | 2 | EFO_0800817 | |
| Disease | 5alpha-androstan-3alpha,17alpha-diol monosulfate measurement | 1.85e-03 | 14 | 136 | 2 | EFO_0800283 | |
| Disease | 16a-hydroxy DHEA 3-sulfate measurement | 2.13e-03 | 15 | 136 | 2 | EFO_0800301 | |
| Disease | X-21410 measurement | 2.43e-03 | 16 | 136 | 2 | EFO_0800813 | |
| Disease | andro steroid monosulfate C19H28O6S (1) measurement | 2.43e-03 | 16 | 136 | 2 | EFO_0800305 | |
| Disease | Liver carcinoma | 2.49e-03 | 507 | 136 | 8 | C2239176 | |
| Disease | Squamous cell carcinoma | 2.64e-03 | 124 | 136 | 4 | C0007137 | |
| Disease | Benign neoplasm of stomach | 2.74e-03 | 17 | 136 | 2 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 2.74e-03 | 17 | 136 | 2 | C0496905 | |
| Disease | Carcinoma in situ of stomach | 2.74e-03 | 17 | 136 | 2 | C0154060 | |
| Disease | Post-Traumatic Osteoporosis | 2.84e-03 | 61 | 136 | 3 | C0751406 | |
| Disease | Osteoporosis, Senile | 2.84e-03 | 61 | 136 | 3 | C0029459 | |
| Disease | Osteoporosis, Age-Related | 2.84e-03 | 61 | 136 | 3 | C0001787 | |
| Disease | 4-ethylphenylsulfate measurement | 3.07e-03 | 18 | 136 | 2 | EFO_0021148 | |
| Disease | 5alpha-androstan-3alpha,17beta-diol monosulfate (1) measurement | 3.07e-03 | 18 | 136 | 2 | EFO_0800288 | |
| Disease | Osteoporosis | 3.11e-03 | 63 | 136 | 3 | C0029456 | |
| Disease | metabolonic lactone sulfate measurement | 3.43e-03 | 19 | 136 | 2 | EFO_0800659 | |
| Disease | etiocholanolone glucuronide measurement | 3.43e-03 | 19 | 136 | 2 | EFO_0800362 | |
| Disease | squamous cell carcinoma | 3.70e-03 | 67 | 136 | 3 | EFO_0000707 | |
| Disease | androsterone glucuronide measurement | 3.79e-03 | 20 | 136 | 2 | EFO_0800317 | |
| Disease | Stomach Carcinoma | 4.18e-03 | 21 | 136 | 2 | C0699791 | |
| Disease | X-24947 measurement | 4.59e-03 | 22 | 136 | 2 | EFO_0800910 | |
| Disease | 5alpha-androstan-3beta,17beta-diol disulfate measurement | 4.59e-03 | 22 | 136 | 2 | EFO_0021115 | |
| Disease | e-selectin measurement | 4.59e-03 | 22 | 136 | 2 | EFO_0004575 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ETRKLMEECKRLQGE | 171 | Q9P0L0 | |
| IMDINKSCKNEERRE | 401 | Q7L4P6 | |
| QARKVLMDCQAKAEE | 431 | Q8N715 | |
| ECKSKEEVMAVRLRE | 636 | Q96CN4 | |
| EEAMKIRKQCALVAL | 96 | O60825 | |
| QKDVCIVLAKEMIRS | 56 | Q9Y3E7 | |
| KIMREKAKERCSEQV | 21 | Q7Z7K0 | |
| LKCIELDERLKAMDQ | 381 | Q9UNS2 | |
| RCAVTEEHMRKKQQE | 91 | Q99708 | |
| QEERKDAVALCSMAK | 341 | Q9UKU7 | |
| EEMRKVVCDQKLRPN | 441 | P36896 | |
| VQRMLEVAEKLKCLD | 106 | Q9H116 | |
| LAECRANREKMKGEL | 66 | Q9NVT9 | |
| IDKKDCDLFQRRMLE | 2751 | Q96DT5 | |
| LVLKEMADLEKRCER | 206 | Q9GZQ3 | |
| MFCSEKKLREVERIV | 1 | Q8TF62 | |
| ERMDQCEKEKAGRKI | 921 | Q8IYA2 | |
| RHKMDKEINNRTCEV | 166 | O43520 | |
| MADKRKLQGEIDRCL | 1 | O75175 | |
| LCKRMIETAQVDERA | 176 | Q9UL25 | |
| KENREKRMIKRACEQ | 301 | Q6ZSC3 | |
| KQTFERLVDIICDKM | 181 | Q96E17 | |
| EETRRQKELLCKMER | 521 | O75154 | |
| LDMARVCSKREKRVA | 1446 | Q14573 | |
| IMVLFATRCNREKKD | 716 | Q9HCL0 | |
| KEMRANVVAECTLKE | 311 | Q9UJU2 | |
| KERISDMCKENRESL | 216 | P49736 | |
| VTLECVEKLIRKDMV | 246 | Q9Y314 | |
| AEEREMIQKECAAIR | 21 | O43747 | |
| KSKTRELECMRALEE | 46 | Q8N9R6 | |
| QLKEMCRRELDKAES | 911 | Q9Y3P9 | |
| RDPECQRTEMIKKEE | 526 | Q8WVC0 | |
| SVRKMDDKDAAAICQ | 296 | P43304 | |
| MRQREELEDKVAACQ | 411 | O60299 | |
| DVATVCRQLAEKRML | 226 | Q9NZL9 | |
| IRRCLKKAIEITECM | 366 | Q9C0I1 | |
| KTERARDMKCLVEKL | 2086 | O95714 | |
| TMCKAKLEREAERKN | 741 | Q9NQ38 | |
| VAKLRDEIMALRNEC | 466 | Q03001 | |
| CCRAEQEIMKKVREA | 336 | Q9NZI8 | |
| VIAKIQEICERKMAR | 21 | A6NL99 | |
| DLSEKEKAIVREMCN | 376 | A6NKD9 | |
| MRLERVCKKDVEING | 371 | P08684 | |
| EEECSRQMQTEKKRL | 951 | Q7Z406 | |
| VRDRCKKEFTDLMTE | 1536 | O43157 | |
| LEMNEAKVKETLRRC | 136 | Q8IVT5 | |
| MKAFCRRELELKEAA | 581 | Q1X8D7 | |
| KRDILNTVADRCEML | 306 | Q5SWX8 | |
| MDAKARADCIKEIDL | 71 | Q8TDX7 | |
| CKNKEEVMAVRLREA | 641 | O60447 | |
| DNEEAMKVRKQCALA | 91 | Q16875 | |
| KDMRADICVHLNRKV | 561 | O95259 | |
| MELKTKARELREECR | 91 | Q9UN81 | |
| EERMATEKRQLECQR | 331 | P12525 | |
| RAKEEEMKRFCKAQT | 916 | Q8TDZ2 | |
| KERMGEQEKTQEERC | 531 | A0A1B0GV03 | |
| ELMKELFDQCENKRR | 246 | Q9NZ52 | |
| CERDIRRLMDEIKGK | 201 | Q96N16 | |
| MEEKMRNIREVKCRV | 766 | Q7L590 | |
| EDRCIQKKILMRKTE | 71 | Q9NY56 | |
| EECKDLIKFMLRNER | 61 | Q3BBV0 | |
| DLMNCVQERAKIEKA | 41 | Q9BY11 | |
| VDMDICRRIDITAKL | 326 | Q0D2I5 | |
| LSDKECAVRRVKTQM | 906 | O43283 | |
| MRKAIEIDEQQGCKE | 186 | Q9NVK5 | |
| VDMVDCLRQKSAKEL | 346 | Q9NZ94 | |
| EDRCIQKKILMRKTE | 71 | Q9NPH6 | |
| LEKEARRQLVDEVMC | 381 | Q96M91 | |
| EMIKIRSCAERETKK | 176 | Q14331 | |
| EEKNRAIIQEVCFMK | 76 | O14976 | |
| RVKEVEEMCKRSLES | 2151 | Q13315 | |
| REVAESCKDIKFNEM | 216 | P50213 | |
| AMDVIVKVIKRCDII | 41 | Q13609 | |
| IMRCGEAVEKNKRLI | 2021 | Q8NF50 | |
| EIVKCENATVMDKAR | 41 | Q5XLA6 | |
| QMEVCRLKKEEEDRI | 176 | Q8NHQ1 | |
| VVLEESKALVRCNMK | 546 | Q9Y232 | |
| ERCKERVNALAIAVM | 101 | O43323 | |
| EMVKKSERVLRENQC | 116 | Q16878 | |
| VINRDTKRCLEMKKD | 591 | Q9NY28 | |
| MEKVLGRLKDEEIRC | 236 | Q13617 | |
| EIKRAEDLCRLMKEK | 81 | Q86V48 | |
| MKRLEVDIDIKIRSC | 166 | P02671 | |
| CRKLILCADNRKEME | 121 | Q16760 | |
| ASAEKAARQMRKCEQ | 236 | Q92551 | |
| MAMVIKDDRLNKDRC | 56 | Q7Z4H3 | |
| VLLKRCVMDDDNEVR | 511 | Q9Y678 | |
| RAVLGEVKLCEKMAQ | 201 | P26641 | |
| KRKREDDKLVVECVM | 106 | P15090 | |
| EEDRRKMQDKCREVL | 566 | P17066 | |
| RENIVDVKDVMGLKC | 3796 | Q8NDH2 | |
| EEQDIVMKKQVIRRC | 5826 | Q8NDH2 | |
| MRLERVCKKDVEING | 371 | P24462 | |
| ERMDQCEKEKAGRKI | 1111 | A2RUR9 | |
| EVVIKQMKECNATRR | 81 | Q8N6R0 | |
| RAVKERMDRQCAQVK | 126 | O95810 | |
| LQFKMDACSTEERKR | 186 | O76038 | |
| RQKEEALVQREKMCL | 111 | Q7L3B6 | |
| EMIDTARNKARVKAC | 96 | Q5T6X4 | |
| QREEQCREMERLIKK | 76 | Q13371 | |
| RVCFEMKINEEISVK | 256 | Q9BUJ2 | |
| EKECERRVAAKQLEM | 626 | Q02241 | |
| SKRRQEEMLKTEEAC | 1291 | Q7Z2Y5 | |
| AARNCMLDEKFTVKV | 1206 | P08581 | |
| KCLEEMKREARTIKI | 76 | Q9Y5W8 | |
| EQRMLDCKRVLDGVK | 1441 | P46939 | |
| EIEMEAERVAKRKCP | 166 | Q96DX7 | |
| MKKRVEDAFILICNV | 221 | Q92526 | |
| ERDVVIRLMNKCEDI | 451 | Q9H4L7 | |
| KMESICQARAKELED | 1926 | Q8WXH0 | |
| EECKDLIKFMLRNER | 61 | P0DPF3 | |
| EECKDLIKFMLRNER | 61 | Q6P3W6 | |
| EECKDLIKFMLRNER | 61 | Q86T75 | |
| EECKDLIKFMLRNER | 61 | Q5TAG4 | |
| EECKDLIKFMLRNER | 61 | Q8N660 | |
| EECKDLIKFMLRNER | 61 | A0A087WUL8 | |
| LRKCKEAGMREQCVL | 146 | P55055 | |
| NRAVTCMLRKEKEAA | 1016 | P28715 | |
| CMLRKEKEAAASEIE | 1021 | P28715 | |
| RRMEEQRKAACAEKL | 471 | Q9Y520 | |
| MAEREIVRDIKEKLC | 866 | P0CG39 | |
| VMRKAVQVDDDQFCK | 151 | Q9BRV8 | |
| KMCKRNEFESVLALV | 431 | Q9NZQ3 | |
| ELKRCVCERRAGMVK | 251 | Q8NC01 | |
| CEECQKAKDRMERIT | 466 | Q8TCY9 | |
| EESIMNIIRKEVEKC | 116 | Q9UJT1 | |
| MVLRRAAQEKDKGVC | 41 | Q6ZV60 | |
| LRLRKDCESVNEGKM | 111 | A8MXY4 | |
| LLEDAIEVCKKFMER | 201 | P15374 | |
| QQMLRRKVVDCSREE | 11 | P30825 | |
| CVMRVDEKTKEVIQE | 336 | Q9Y490 | |
| RKDILKDLVEMCRGV | 126 | Q96QK1 | |
| MIEVVCNDRLGKKVR | 1 | Q9BZL1 | |
| DAMRDLAQCVNEVKR | 361 | P15498 | |
| VAKDMAAAAVRCIRK | 206 | O00442 | |
| MECAEKQGQIERVIK | 406 | Q96NL6 | |
| QEACMRKEKSVAVLE | 141 | Q6ZMU5 | |
| CRKDVEMEPVQQAEK | 1206 | Q13464 | |
| KMENEKLVLACEDVR | 676 | Q15643 | |
| VACKVKADQDSEAMR | 2441 | Q9Y4G6 | |
| AAEECRVQKLIKEMD | 131 | A6NLI5 | |
| RREIEAIQCEVRKMC | 1401 | Q9Y6X0 | |
| RVANCQTVRMKEEKE | 616 | Q9Y4A5 | |
| AEACDIMVKRGDKKR | 646 | O94874 | |
| SLDICRKMEKEAAVA | 121 | Q8NAP8 | |
| RFQDEKNKEVVLMCI | 321 | Q8TF71 | |
| ETQRTFLKEVKVMRC | 376 | P53667 |